NEK2 and breast carcinoma: Except for the case where we reported that NEK2 induced bortezomib based drug resistance mainly through activation of efflux drug pumps, other groups indicated high NEK2 promotes paclitaxel and doxorubicin based drug resistance through inhibiting cell apoptosis in breast cancer cell.39 In this study, we firstly identified high NEK2 conferred to cisplatin‐based chemotherapy in clinical samples and also further confirmed the mechanisms of resistance to cisplatin through decreasing cell apoptosis.